Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Acasti Pharma Inc ACST

Acasti Pharma Inc. is a Canada-based late-stage biopharma company with drug candidates addressing rare and orphan diseases. The Company is targeting three underserved orphan diseases: GTX-104, an intravenous infusion targeting subarachnoid hemorrhage (SAH), a rare and life-threatening medical emergency, in which bleeding occurs over the surface of the brain in the subarachnoid space between the brain and skull; GTX-102, an oral mucosal spray targeting ataxia-telangiectasia (A-T), a progressive, neurodegenerative genetic disease that primarily impacts children causing severe disability; and GTX-101, a topical spray, targeting postherpetic neuralgia, a persistent and often debilitating neuropathic pain caused by nerve damage from the varicella zoster virus (shingles). The Company’s clinical assets have each been granted Orphan Drug Designation by the FDA, which provides seven years of marketing exclusivity post-launch in the United States, and additional intellectual property protection.


NDAQ:ACST - Post by User

Comment by Blairman1on Apr 20, 2019 9:18am
42 Views
Post# 29650643

RE:NO PUMPERS LEFT

RE:NO PUMPERS LEFTLMAO. Happy Easter Boozehound.  You clearly are not a Catholic <br /> i hold 40000 Shares of Acasti. And I am holding until the final PH3 amp;nbsp;<br /> trials are released.  I don’t pump stocks , I state facts<br /> everyone knows anyone on these boards that is always <br /> bashing a stock is either a person trying to short the stock or hope that their negative comments will drive the stock down so that person can Buy more. <br /> Only an Amateur would believe that a few negative or Positive posts can move a stock in either direction. <br /> Acasti will stay were it is until late summer, then you will see some <br /> accumulation from institutional Investors IMHO in anticipation of the PHase 3 release<br /> <br /> go to Church Boozehound
<< Previous
Bullboard Posts
Next >>